Northland Securities analyst James Terwilliger maintained a Hold rating on Milestone Scientific (MLSS) today. The company’s shares closed last Thursday at $3.72.
According to TipRanks.com, Terwilliger is a 4-star analyst with an average return of 21.9% and a 80.0% success rate. Terwilliger covers the Healthcare sector, focusing on stocks such as Cardiovascular Systems, Sensus Healthcare, and Electromed.
Milestone Scientific has an analyst consensus of Moderate Buy, with a price target consensus of $7.00.
See today’s analyst top recommended stocks >>
Based on Milestone Scientific’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $1.25 million and GAAP net loss of $1.49 million. In comparison, last year the company earned revenue of $1.9 million and had a GAAP net loss of $2.84 million.
Based on the recent corporate insider activity of 45 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of MLSS in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Milestone Scientific, Inc. engages in the provision of pioneering proprietary, innovative technological systems and solutions. It also involves in the development, manufacture, market, and selling of computer controlled system for the improved and painless delivery of local anesthetic. It operates through the Dental and Medical segments. The company was founded on August 17, 1989 and is headquartered in Livingston, NJ.
